HealthBiome

HealthBiome,

a leading Bio-venture Company Specialized in
Strict Anaerobic Gut Microbiome R&D

Over the last 20 years, it has been scientifically proven that it is not lactic acid bacteria that play a key role in treating and preventing human diseases, but strict anaerobic microbiota which account for 99.9% of the human intestines.

01 02 03

HealthBiome,

a leading Bio-venture Company Specialized in
Strict Anaerobic Gut Microbiome R&D

In order to overcome refractory diseases such as cancer, dementia, and metabolic disorders in the 21st. century, large-scale investments have been made in developing new drugs using strict anaerobic microbiome in the US and the EU

01 02 03

HealthBiome,

a leading Bio-venture Company Specialized in
Strict Anaerobic Gut Microbiome R&D

HealthBiome Inc. is a next-generation microbiome-based drug R&D venture company with strict anaerobic microbiome mass production technology, multi-omics analysis, and non-clinical animal testing capabilities

01 02 03

HealthBiome,

the Bio-venture Company Specialized in
Strict Anaerobic Gut Microbiome R&D

Scientifically proven that it is not lactic acid bacteria but strict anaerobic microbiota comprising 99.9% in human gut that play key roles in treating and preventing human diseases for the last 20 years

01 02 03

HealthBiome,

the Bio-venture Company Specialized in
Strict Anaerobic Gut Microbiome R&D

In order to overcome refractory diseases such as cancer, dementia, and metabolic disorders in the 21st. century, large-scale investments have been made in developing new drugs using strict anaerobic microbiome in the US and the EU

01 02 03

HealthBiome,

the Bio-venture Company Specialized in
Strict Anaerobic Gut Microbiome R&D

HealthBiome Inc. is a next-generation microbiome-based drug R&D venture company with strict anaerobic microbiome mass production technology, multi-omics analysis, and non-clinical animal testing capabilities

01 02 03

BUSINESS

HealthBiome Inc. is a leading bio-venture company with its own effective strains for treating diseases and has carried out R&D in microbiome-based drug discovery using strict anerobic gut microbiota identification and production technology